Ranjbar, K., Moghadami, M., Mirahmadizadeh, A., Fallahi, M. J., Khaloo, V., Shahriarirad, R., . . . Gholampoor Saadi, M. H. (2021). Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: A triple-blinded randomized controlled trial. BMC infectious diseases, 21(1), 337-8. https://doi.org/10.1186/s12879-021-06045-3
Chicago Style (17th ed.) CitationRanjbar, Keivan, Mohsen Moghadami, Alireza Mirahmadizadeh, Mohammad Javad Fallahi, Vahid Khaloo, Reza Shahriarirad, Amirhossein Erfani, Zohre Khodamoradi, and Mohammad Hasan Gholampoor Saadi. "Methylprednisolone or Dexamethasone, Which One Is Superior Corticosteroid in the Treatment of Hospitalized COVID-19 Patients: A Triple-blinded Randomized Controlled Trial." BMC Infectious Diseases 21, no. 1 (2021): 337-8. https://doi.org/10.1186/s12879-021-06045-3.
MLA (9th ed.) CitationRanjbar, Keivan, et al. "Methylprednisolone or Dexamethasone, Which One Is Superior Corticosteroid in the Treatment of Hospitalized COVID-19 Patients: A Triple-blinded Randomized Controlled Trial." BMC Infectious Diseases, vol. 21, no. 1, 2021, pp. 337-8, https://doi.org/10.1186/s12879-021-06045-3.